Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_2
1
11%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
Recruiting2
unknown2
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
N/A7 (77.8%)

Trials by Status

withdrawn111%
recruiting222%
completed333%
enrolling_by_invitation111%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9